META-AF: Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation
The META-AF study demonstrated that metformin use significantly reduced atrial arrhythmia recurrence in overweight or obese patients undergoing atrial fibrillation ablation, even in the absence of diabetes.
TribeMD
3 min read
November 10, 2025
Carregando conteúdo…
Cardiology
AHA®2025
Highlights
SnackableHealth® |Non-cardiac effects in HELIOS-B trial: gastrointestinal symptoms and quality-of-life signals discussed by Drs. Mike Gibson and Tony Urey
ASCO GU® 2026
Trastuzumab deruxtecan (T-DXd) Provides Significant Clinical Benefit Over Trastuzumab emtansine (T-DM1), Marking a Potential Shift in the Therapeutic Standard for HER2+ Breast Cancer
SnackableHealth® |Non-cardiac effects in HELIOS-B trial: gastrointestinal symptoms and quality-of-life signals discussed by Drs. Mike Gibson and Tony Urey
ASCO GU® 2026
Trastuzumab deruxtecan (T-DXd) Provides Significant Clinical Benefit Over Trastuzumab emtansine (T-DM1), Marking a Potential Shift in the Therapeutic Standard for HER2+ Breast Cancer